These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11849851)

  • 1. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.
    van den Brand MJ; Rensing BJ; Morel MA; Foley DP; de Valk V; Breeman A; Suryapranata H; Haalebos MM; Wijns W; Wellens F; Balcon R; Magee P; Ribeiro E; Buffolo E; Unger F; Serruys PW
    J Am Coll Cardiol; 2002 Feb; 39(4):559-64. PubMed ID: 11849851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
    Serruys PW; Unger F; Sousa JE; Jatene A; Bonnier HJ; Schönberger JP; Buller N; Bonser R; van den Brand MJ; van Herwerden LA; Morel MA; van Hout BA;
    N Engl J Med; 2001 Apr; 344(15):1117-24. PubMed ID: 11297702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).
    Bourassa MG; Kip KE; Jacobs AK; Jones RH; Sopko G; Rosen AD; Sharaf BL; Schwartz L; Chaitman BR; Alderman EL; Holmes DR; Roubin GS; Detre KM; Frye RL
    J Am Coll Cardiol; 1999 May; 33(6):1627-36. PubMed ID: 10334434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina.
    de Feyter PJ; Serruys PW; Unger F; Beyar R; de Valk V; Milo S; Simon R; Regensburger D; Crean PA; McGovern E; van den Heuvel P; van Cauwelaert C; Penn I; Tyers GF; Lindeboom W
    Circulation; 2002 May; 105(20):2367-72. PubMed ID: 12021222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.
    Halon DA; Merdler A; Flugelman MY; Shifroni G; Khader N; Shiran A; Shahla J; Lewis BS
    Am J Cardiol; 1998 Sep; 82(5):547-53. PubMed ID: 9732877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
    Gruberg L; Mercado N; Milo S; Boersma E; Disco C; van Es GA; Lemos PA; Ben Tzvi M; Wijns W; Unger F; Beyar R; Serruys PW;
    Am J Cardiol; 2005 Feb; 95(4):439-44. PubMed ID: 15695125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems.
    Laham RJ; Carrozza JP; Berger C; Cohen DJ; Kuntz RE; Baim DS
    J Am Coll Cardiol; 1996 Oct; 28(4):820-6. PubMed ID: 8837554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.
    Singh M; Lennon RJ; Darbar D; Gersh BJ; Holmes DR; Rihal CS
    Mayo Clin Proc; 2004 Sep; 79(9):1113-8. PubMed ID: 15357032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.
    Rodriguez A; Bernardi V; Navia J; Baldi J; Grinfeld L; Martinez J; Vogel D; Grinfeld R; Delacasa A; Garrido M; Oliveri R; Mele E; Palacios I; O'Neill W
    J Am Coll Cardiol; 2001 Jan; 37(1):51-8. PubMed ID: 11153772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?
    Bell MR; Bailey KR; Reeder GS; Lapeyre AC; Holmes DR
    J Am Coll Cardiol; 1990 Sep; 16(3):553-62. PubMed ID: 2387928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).
    Rodriguez A; Mele E; Peyregne E; Bullon F; Perez-Baliño N; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1996 Apr; 27(5):1178-84. PubMed ID: 8609339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial.
    Vieira RD; Hueb W; Gersh BJ; Lima EG; Pereira AC; Rezende PC; Garzillo CL; Hueb AC; Favarato D; Soares PR; Ramires JA; Kalil Filho R
    Circulation; 2012 Sep; 126(11 Suppl 1):S158-63. PubMed ID: 22965977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization.
    Kloeter UC; Jander NG; Buser PT; Osswald S; Mueller-Brand J; Pfisterer ME
    Int J Cardiol; 2001 Jul; 79(2-3):197-205. PubMed ID: 11461742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI).
    Vander Salm TJ; Kip KE; Jones RH; Schaff HV; Shemin RJ; Aldea GS; Detre KM
    J Am Coll Cardiol; 2002 Feb; 39(4):565-72. PubMed ID: 11849852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.